![](https://library.celltelligence.com/wp-content/uploads/2021/10/JNJ_Earnings.png)
$0
No Carvykti Revenue Disclosed; JNJ Q2 2022 Earnings Call Summary
On Tuesday, July 19, JNJ held their Q2 2022 earnings call (press release / presentation) highlighting Carvykti’s (JNJ / Legend’s BCMA CAR-T) US launch in April 2022, and subsequent EC conditional approval for ≥4L MM in May 2022. Below, Celltelligence provides insights on Carvykti’s potential US and EU launch strategy, while comparing it with key competitor Abecma (BMS’s BCMA CAR-T).